Thromb Haemost 1989; 61(02): 294-297
DOI: 10.1055/s-0038-1646579
Original Article
Schattauer GmbH Stuttgart

Heparin Inhibition of Endotoxin-Dependent Limulus Amebocyte Lysate Coagulation[*]

James A Marcum
The Marine Biological Laboratory Woods Hole, MA; the Department of Pathology, Harvard Medical School, Boston, MA; the Department of Biology, MIT, Cambridge, MA; and the Departments of Laboratory Medicine and Medicine, University of California School of Medicine, San Francisco, CA, USA
,
Jack Levin
The Marine Biological Laboratory Woods Hole, MA; the Department of Pathology, Harvard Medical School, Boston, MA; the Department of Biology, MIT, Cambridge, MA; and the Departments of Laboratory Medicine and Medicine, University of California School of Medicine, San Francisco, CA, USA
› Author Affiliations
Further Information

Publication History

Received 11 November 1988

Accepted after revision 18 November 1988

Publication Date:
30 June 2018 (online)

Summary

Addition of commercial heparin to preparations of the coagulation system obtained by hypotonic lysis of Limulus amebocytes, prior to the addition of endotoxin from gram-negative bacteria, inhibited gelation. Activation of the cell-lysate proclotting enzyme, utilizing a diluted lysate preparation and synthetic substrates, was inhibited to a comparable extent with either anticoagulantly active or inactive heparin. Other glycosaminoglycans, including heparan sulfate, dermatan sulfate, chondroitin 4-sulfate, and chondroitin 6-sulfate, did not inhibit the generation of clotting enzyme activity. Experiments conducted with preparations of proactivator(s) and proclotting enzyme, obtained by fractionation of lysate with heparin-Sepharose, revealed that inhibition of endotoxin-dependent activation of amebocyte lysate by heparin is mediated by precipitation of the proactivator(s) and can be prevented by increasing the salt concentration.

Supported, in part, by a Summer Fellowship (Marine Biological Laboratory, Woods Hole, MA) awarded to J.A.M.; Research Grants HL34800 and HL31035 from the National Heart, Lung, and Blood Institute, N. I. H., Bethesda, MD; and the Veterans Administration.


 
  • References

  • 1 Rosenberg RD, Damus PS. The purification and mechanism of action of human antithrombin-heparin cofactor. J Biol Chem 1973; 248: 6490-6505
  • 2 Cassaro CM F, Dietrich CP. Distribution of sulfated mucopolysaccharides in invertebrates. J Biol Chem 1977; 252: 2254-2261
  • 3 Jordan RE, Marcum JA. Anticoagulantly active heparin from clam (Mercinaria mercinaria). Arch Biochem Biophys 1986; 248: 690-695
  • 4 Sullivan Jr JD, Watson SW. Inhibitory effect of heparin on the Limulus test for endotoxin. J Clin Microbiol 1975; 2: 151
  • 5 Hook M, Bjork I, Hopwood J, Lindahl U. Anticoagulant activity of heparin: Separation of high-affinity and low-affinity heparin species by affinity chromatography on immobilized antithrombin. FEBS Lett 1976; 66: 90-94
  • 6 Levin J, Bang FB. Clottable protein in Limulus: Its localization and kinetics of its coagulation by endotoxin. Thromb Diath Haemorrh 1968; 19: 186-197
  • 7 Nakamura S, Levin J. Fractionation of Limulus amebocyte lysate: Characterization of activation of the proclotting enzyme by an endotoxin-mediated activator. Biochim Biophys Acta 1982; 707: 217-225
  • 8 Bitter T, Muir HM. A modified uronic acid carbazole reaction. Anal Biochem 1962; 4: 330-334
  • 9 Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254
  • 10 Levin J, Bang FB. A description of cellular coagulation in the Limulus. Bull Johns Hopkins Hosp 1964; 115: 337-345
  • 11 Nakamura S, Levin J. Endotoxin-mediated Limulus proclotting enzyme activator and detection of a previously undescribed protease (Protease N). Biochem Biophys Res Commun 1982; 108: 1619-1623
  • 12 Levin J, Bang FB. The role of endotoxin in the extracellular coagulation of Limulus blood. Bull Johns Hopkins Hosp 1964; 115: 265-274
  • 13 Jordan RE. Antithrombin in vertebrate species: Conservation of the heparin-dependent anticoagulant mechanism. Arch Biochem Biophys 1983; 227: 587-595